46 related articles for article (PubMed ID: 20156107)
1. HIV type 1 B'/C recombinant (CRF07_BC) in virologic noncontrollers elicits neutralizing antibodies against heterologous but not autologous viruses.
Sun J; Ma L; Jiang S; Shao Y
AIDS Res Hum Retroviruses; 2010 Feb; 26(2):237-9. PubMed ID: 20156107
[No Abstract] [Full Text] [Related]
2. Identification and characterization of broadly cross-reactive neutralizing antibodies in patients infected with HIV-1 B'/C recombinant (CRF07_BC).
Bao MJ; Geng WQ; Cui HL; Zhang XL; Xu DB; Nian H; Dai D; Wang YN; Shang H
Mol Med Rep; 2012 May; 5(5):1311-7. PubMed ID: 22344547
[TBL] [Abstract][Full Text] [Related]
3. Comparisons of the genetic and neutralization properties of HIV-1 subtype C and CRF07/08_BC env molecular clones isolated from infections in China.
Wang S; Nie J; Wang Y
Virus Res; 2011 Jan; 155(1):137-46. PubMed ID: 20875470
[TBL] [Abstract][Full Text] [Related]
4. Profiling the neutralizing antibody response in chronically HIV-1 CRF07_BC-infected intravenous drug users naïve to antiretroviral therapy.
Hu X; Hu Y; Zhao C; Gao H; Greene KM; Ren L; Ma L; Ruan Y; Sarzotti-Kelsoe M; Montefiori DC; Hong K; Shao Y
Sci Rep; 2017 Apr; 7():46308. PubMed ID: 28387330
[TBL] [Abstract][Full Text] [Related]
5. Lower anti-HIV-1 neutralization in HIV-infected children with CD4+ T cell depletion: opposite correlation to that in adults.
Agthe M; Nemes E; Jacob RA; Abrahams F; Fainguem N; Tetang SM; Cappelli G; Colizzi V; Dorfman JR
AIDS; 2014 Jul; 28(11):1694-6. PubMed ID: 25232903
[No Abstract] [Full Text] [Related]
6. Catch Me If You Can--The Race Between HIV and Neutralizing Antibodies.
Geiß Y; Dietrich U
AIDS Rev; 2015; 17(2):107-13. PubMed ID: 26035168
[TBL] [Abstract][Full Text] [Related]
7. Characterization of anti-HIV-1 neutralizing and binding antibodies in chronic HIV-1 subtype C infection.
Archary D; Rong R; Gordon ML; Boliar S; Madiga M; Gray ES; Dugast AS; Hermanus T; Goulder PJ; Coovadia HM; Werner L; Morris L; Alter G; Derdeyn CA; Ndung'u T
Virology; 2012 Nov; 433(2):410-20. PubMed ID: 22995189
[TBL] [Abstract][Full Text] [Related]
8. A single amino-acid change in a highly conserved motif of gp41 elicits HIV-1 neutralization and protects against CD4 depletion.
Petitdemange C; Achour A; Dispinseri S; Malet I; Sennepin A; Ho Tsong Fang R; Crouzet J; Marcelin AG; Calvez V; Scarlatti G; Debré P; Vieillard V
Clin Infect Dis; 2013 Sep; 57(5):745-55. PubMed ID: 23696512
[TBL] [Abstract][Full Text] [Related]
9. Reconstitution and characterization of antibody repertoires of HIV-1-infected "elite neutralizers".
Sun Z; Li J; Hu X; Shao Y; Zhang MY
Antiviral Res; 2015 Jun; 118():1-9. PubMed ID: 25770672
[TBL] [Abstract][Full Text] [Related]
10. Antibodies that cross-neutralize the tier-2 pseudoviruses are produced in antiretroviral-naïve HIV-1-infected children from northern India.
Prakash SS; Andrabi R; Kumar R; Lodha R; Kabra SK; Vajpayee M; Luthra K
Arch Virol; 2012 Sep; 157(9):1797-801. PubMed ID: 22674340
[TBL] [Abstract][Full Text] [Related]
11. Similar neutralizing activity in the HIV-1 infected long term non-progressors(LTNPs) and typical progressors(TPs).
Wang Z; Li TY; Li JY; Chen LL; Liu YJ; Li HP; Bao ZY; Wang XL; Zhuang DM; Liu SY; Li L
Virol Sin; 2012 Jun; 27(3):165-71. PubMed ID: 22684470
[TBL] [Abstract][Full Text] [Related]
12. Optimization and proficiency testing of a pseudovirus-based assay for detection of HIV-1 neutralizing antibody in China.
Nie J; Wang W; Wen Z; Song A; Hong K; Lu S; Zhong P; Xu J; Kong W; Li J; Shang H; Ling H; Ruan L; Wang Y
J Virol Methods; 2012 Nov; 185(2):267-75. PubMed ID: 22796285
[TBL] [Abstract][Full Text] [Related]
13. Antibody-dependent cell-mediated virus inhibition antibody activity does not correlate with risk of HIV-1 superinfection.
Forthal DN; Landucci G; Chohan B; Richardson BA; McClelland RS; Jaoko W; Blish C; Overbaugh J
J Acquir Immune Defic Syndr; 2013 May; 63(1):31-3. PubMed ID: 23344546
[TBL] [Abstract][Full Text] [Related]
14. Emergence of monoclonal antibody b12-resistant human immunodeficiency virus type 1 variants during natural infection in the absence of humoral or cellular immune pressure.
Bunnik EM; van Gils MJ; Lobbrecht MS; Pisas L; Nanlohy NM; van Baarle D; van Nuenen AC; Hessell AJ; Schuitemaker H
J Gen Virol; 2010 May; 91(Pt 5):1354-64. PubMed ID: 20053822
[TBL] [Abstract][Full Text] [Related]
15. Variables influencing anti-human immunodeficiency virus type 1 neutralizing human monoclonal antibody (NhMAb) production among infected Thais.
Akapirat S; Avihingsanon A; Ananworanich J; Schuetz A; Ramasoota P; Luplertlop N; Ono K; Ikuta K; Utachee P; Kameoka M; Leaungwutiwong P
Southeast Asian J Trop Med Public Health; 2013 Sep; 44(5):825-41. PubMed ID: 24437318
[TBL] [Abstract][Full Text] [Related]
16. Generation of HIV-1 potent and broad neutralizing antibodies by immunization with postfusion HR1/HR2 complex.
Dawood R; Benjelloun F; Pin JJ; Kone A; Chanut B; Jospin F; Lucht F; Verrier B; Moog C; Genin C; Paul S
AIDS; 2013 Mar; 27(5):717-30. PubMed ID: 23719346
[TBL] [Abstract][Full Text] [Related]
17. Viral evolution in macaques coinfected with CCR5- and CXCR4-tropic SHIVs in the presence or absence of vaccine-elicited anti-CCR5 SHIV neutralizing antibodies.
Burke B; Derby NR; Kraft Z; Saunders CJ; Dai C; Llewellyn N; Zharkikh I; Vojtech L; Zhu T; Srivastava IK; Barnett SW; Stamatatos L
Virology; 2006 Nov; 355(2):138-51. PubMed ID: 16920175
[TBL] [Abstract][Full Text] [Related]
18. Anti-V3/Glycan and Anti-MPER Neutralizing Antibodies, but Not Anti-V2/Glycan Site Antibodies, Are Strongly Associated with Greater Anti-HIV-1 Neutralization Breadth and Potency.
Jacob RA; Moyo T; Schomaker M; Abrahams F; Grau Pujol B; Dorfman JR
J Virol; 2015 May; 89(10):5264-75. PubMed ID: 25673728
[TBL] [Abstract][Full Text] [Related]
19. Efficient neutralization of primary isolates by the plasma from HIV-1 infected Indian children.
Prakash SS; Chaudhary AK; Lodha R; Kabra SK; Vajpayee M; Hazarika A; Bagga B; Luthra K
Viral Immunol; 2011 Oct; 24(5):409-13. PubMed ID: 22004138
[TBL] [Abstract][Full Text] [Related]
20. HIV-1 vaccines based on replication-competent Tiantan vaccinia protected Chinese rhesus macaques from simian HIV infection.
Liu Q; Li Y; Luo Z; Yang G; Liu Y; Liu Y; Sun M; Dai J; Li Q; Qin C; Shao Y
AIDS; 2015 Mar; 29(6):649-58. PubMed ID: 25849828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
